- The RAD52-S346X variant reduces risk of developing breast cancer in carriers of pathogenic germline BRCA2 mutations.
- Adamson AW, Ding YC, Mendez-Dorantes C, Bailis AM, Stark JM, Neuhausen SL.
- Mol Oncol. 2020 Mar 16. doi: 10.1002/1878-0261.12665. [Epub ahead of print]
- PMID: 32175645
- PubMed abstract
- Source abstract